Thioridazine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00679 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | manic bipolar affective disorder | KG + DL |
| 2 | Tourette syndrome | KG + DL |
| 3 | trichotillomania | KG + DL |
| 4 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 5 | major affective disorder | KG + DL |
| 6 | bipolar disorder | KG + DL |
| 7 | obsessive-compulsive disorder | KG + DL |
| 8 | attention deficit-hyperactivity disorder | KG + DL |
| 9 | histrionic personality disorder (disease) | KG + DL |
| 10 | schizoid personality disorder | KG + DL |
| 11 | schizotypal personality disorder | KG + DL |
| 12 | paranoid personality disorder | KG + DL |
| 13 | schizophreniform disorder | KG + DL |
| 14 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 15 | Malan overgrowth syndrome | KG + DL |
| 16 | anaphylaxis | KG + DL |
| 17 | faciodigitogenital syndrome | KG + DL |
| 18 | schizophrenia | KG + DL |
| 19 | distal 17p13.3 microdeletion syndrome | KG + DL |
| 20 | psychotic disorder | KG + DL |
| 21 | dysthymic disorder | KG + DL |
| 22 | headache disorder | KG + DL |
| 23 | anxiety disorder | KG + DL |
| 24 | chondromyxoid fibroma | KG + DL |
| 25 | specific developmental disorder | KG + DL |
| 26 | common cold | KG + DL |
| 27 | bronchial disease | KG + DL |
| 28 | food-dependent exercise-induced anaphylaxis | KG + DL |
| 29 | diabetes insipidus, nephrogenic, X-linked | KG + DL |
| 30 | hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome | KG + DL |
| 31 | agoraphobia | KG + DL |
| 32 | trigeminal autonomic cephalalgia | KG + DL |
| 33 | schizoaffective disorder | KG + DL |
| 34 | REM sleep behavior disorder | KG + DL |
| 35 | psychosexual disorder | KG + DL |
| 36 | benign paroxysmal torticollis of infancy | KG + DL |
| 37 | treatment-refractory schizophrenia | KG + DL |
| 38 | early-onset schizophrenia | KG + DL |
| 39 | angioedema | KG + DL |
| 40 | mental disorder | KG + DL |
| 41 | progressive supranuclear palsy | KG + DL |
| 42 | myofascial pain syndrome | KG + DL |
| 43 | intermittent explosive disorder | KG + DL |
| 44 | impulse control disorder | KG + DL |
| 45 | tremor, hereditary essential | KG + DL |
| 46 | syndromic myopia | KG + DL |
| 47 | allergic urticaria | KG + DL |
| 48 | polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | KG + DL |
| 49 | congenital disorder of glycosylation with defective fucosylation | KG + DL |
| 50 | fibromyalgia | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.